Restrictive Fluid Therapy for High-Complexity Advanced Ovarian Cancer Surgery: A Single-Center Retrospective Cohort Study

Background: Postoperative fluid management is vital for preventing perioperative morbidity and mortality in high-complexity advanced ovarian cancer surgery. We investigated the feasibility benefits of restrictive therapy on postoperative recovery. Methods: Patients with who underwent open radical surgery were randomized into or liberal group. The endpoints length hospital stay post-surgery incidence complications within 30 days. Results: regimen groups included 41 patients, respectively. was 16.5-days 21.0-days group, respectively (p = 0.035). Multiple linear regression analysis showed that 2.971-days shorter group than (95% confidence interval (CI): –5.818~–0.124, p 0.04). at end days significantly lower intravenous (26.7% versus 51.2%; 0.032). Adjusted logistic demonstrated could reduce risk by 68% (Odds Ratio 0.32, 95% CI: 0.11–0.91, 0.033). Conclusions: Restrictive after can decrease major facilitate